Literature DB >> 6329696

Recombinant DNA molecules comprising bovine papilloma virus type 1 DNA linked to plasmid DNA are maintained in a plasmidial state both in rodent fibroblasts and in bacterial cells.

B Binétruy, G Meneguzzi, R Breathnach, F Cuzin.   

Abstract

Transformed cells obtained after transfecting FR3T3 rat fibroblasts with DNA of bovine papilloma virus type 1 ( BPV1 ) maintained only free copies of the viral genome. Transfection with BPV1 DNA inserted in a bacterial plasmid (pBR322 or pML2 ) did not produce transformants at a detectable rate, unless the viral sequences had been first excised from the plasmid. In contrast, transfer of the same plasmids by polyethylene glycol-induced fusion of bacterial protoplasts with FR3T3 rat or C127 mouse cells led to significant transformation frequencies. A total of eight cell lines were studied, three rat and five mouse transformants, obtained with various BPV1 - pML2 recombinants. In all cell lines, both BPV1 and plasmid sequences were maintained as non-integrated molecules, predominantly as oligomeric forms of the transforming DNA. In the three rat transformants and in two of the mouse lines, parts of the non-transforming viral region and some bacterial sequences were deleted. In the remaining three mouse lines, the monomeric repeat was a non-rearranged plasmid molecule which could be re-established as a plasmid in Escherichia coli after cleavage with "one-cut" restriction endonucleases and circularization of the molecule.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6329696      PMCID: PMC553097          DOI: 10.1002/j.1460-2075.1982.tb01218.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  24 in total

1.  Transformation of mammalian cells with genes from procaryotes and eucaryotes.

Authors:  M Wigler; R Sweet; G K Sim; B Wold; A Pellicer; E Lacy; T Maniatis; S Silverstein; R Axel
Journal:  Cell       Date:  1979-04       Impact factor: 41.582

2.  Demonstration of two distinct classes of bovine papilloma virus.

Authors:  W D Lancaster; C Olson
Journal:  Virology       Date:  1978-09       Impact factor: 3.616

3.  Helper-independent transformation by unintegrated Harvey sarcoma virus DNA.

Authors:  D R Lowy; E Rands; E M Scolnick
Journal:  J Virol       Date:  1978-05       Impact factor: 5.103

4.  DNA replication in SV40-infected cells. V. Circular and catenated oligomers of SV40 DNA.

Authors:  R Jaenisch; A Levine
Journal:  Virology       Date:  1971-06       Impact factor: 3.616

5.  Transformation of rat cells by DNA of human adenovirus 5.

Authors:  F L Graham; A J van der Eb
Journal:  Virology       Date:  1973-08       Impact factor: 3.616

6.  Integration sites and sequence arrangement of SV40 DNA in a homogeneous series of transformed rat fibroblast lines.

Authors:  E Mougneau; F Birg; M Rassoulzadegan; F Cuzin
Journal:  Cell       Date:  1980-12       Impact factor: 41.582

7.  Apparent lack of integration of bovine papillomavirus DNA in virus-induced equine and bovine tumor cells and virus-transformed mouse cells.

Authors:  W D Lancaster
Journal:  Virology       Date:  1981-01-30       Impact factor: 3.616

8.  In vitro tumorigenic transformation by a defined sub-genomic fragment of bovine papilloma virus DNA.

Authors:  D R Lowy; I Dvoretzky; R Shober; M F Law; L Engel; P M Howley
Journal:  Nature       Date:  1980-09-04       Impact factor: 49.962

9.  Equine connective tissue tumors contain unintegrated bovine papilloma virus DNA.

Authors:  E Amtmann; H Müller; G Sauer
Journal:  J Virol       Date:  1980-09       Impact factor: 5.103

10.  Direct transfer of cloned genes from bacteria to mammalian cells.

Authors:  W Schaffner
Journal:  Proc Natl Acad Sci U S A       Date:  1980-04       Impact factor: 11.205

View more
  13 in total

Review 1.  The bovine papillomavirus genome and its uses as a eukaryotic vector.

Authors:  P E Stephens; C C Hentschel
Journal:  Biochem J       Date:  1987-11-15       Impact factor: 3.857

2.  A stable bovine papillomavirus hybrid plasmid that expresses a dominant selective trait.

Authors:  M F Law; J C Byrne; P M Howley
Journal:  Mol Cell Biol       Date:  1983-11       Impact factor: 4.272

3.  The molecular biology of papillomavirus transformation. Warner-Lambert Parke-Davis Award Lecture.

Authors:  P M Howley
Journal:  Am J Pathol       Date:  1983-12       Impact factor: 4.307

4.  Tumorigenicity, invasiveness and metastatic capability of FR3T3 rat cells before and after transfection with bovine papilloma virus type 1 DNA.

Authors:  P Coopman; F Van Roy; C Dragonetti; J Gao; W Fiers; G Meneguzzi; M Mareel
Journal:  Clin Exp Metastasis       Date:  1989 Jan-Feb       Impact factor: 5.150

5.  Constitutive production of human interferons by mouse cells with bovine papillomavirus as a vector.

Authors:  R Fukunaga; Y Sokawa; S Nagata
Journal:  Proc Natl Acad Sci U S A       Date:  1984-08       Impact factor: 11.205

6.  Transcriptional organization of bovine papillomavirus type 1.

Authors:  L W Engel; C A Heilman; P M Howley
Journal:  J Virol       Date:  1983-09       Impact factor: 5.103

7.  Fate of exogenous recombinant plasmids introduced into mouse and human cells.

Authors:  G Biamonti; G Della Valle; D Talarico; F Cobianchi; S Riva; A Falaschi
Journal:  Nucleic Acids Res       Date:  1985-08-12       Impact factor: 16.971

8.  Bovine papilloma virus contains an activator of gene expression at the distal end of the early transcription unit.

Authors:  M Lusky; L Berg; H Weiher; M Botchan
Journal:  Mol Cell Biol       Date:  1983-06       Impact factor: 4.272

9.  Replication efficiency of bovine papillomavirus type 1 DNA depends on cis-acting sequences distinct from the replication origin.

Authors:  V Pierrefite; F Cuzin
Journal:  J Virol       Date:  1995-12       Impact factor: 5.103

10.  A bovine papilloma virus vector with a dominant resistance marker replicates extrachromosomally in mouse and E. coli cells.

Authors:  P D Matthias; H U Bernard; A Scott; G Brady; T Hashimoto-Gotoh; G Schütz
Journal:  EMBO J       Date:  1983       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.